News|Videos|September 13, 2023
Interview with Piramal’s Peter DeYoung at DCAT
Author(s)Piramal Pharma Solutions
Advertisement
Key Learning Objectives
- Demonstrate expertise in key areas of drug substance & drug product development and manufacturing with emphasis on APIs and ADCs
- Piramal is expanding to meet current and future market demand
- Piramal is a leader in integrated solutions with 15 sites in NA, EU and India
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Triple-Negative Breast Cancer Deal Signals Oncology Licensing Shift
2
What the OSTP’s New Policy Blueprint Means for Pharma Manufacturing and Development
3
Is Organizational Readiness Pharma's Real AI Barrier in 2026?
4
How to Maintain a Productive Sponsor-CMO Relationship
5